DNA甲基化
表观遗传学
甲基化
癌症研究
癌变
重编程
食管鳞状细胞癌
亚硫酸氢盐测序
食管癌
癌
医学
生物
病理
差异甲基化区
核糖核酸
食管
食道疾病
上皮内瘤变
诊断生物标志物
RNA甲基化
癌症
细胞
生物标志物
表观遗传学
液体活检
胎儿游离DNA
疾病
基底细胞
作者
Yonglin Yi,Dongxu Li,Shaokai Zhang,Yali Bai,Yuan Lin,Yin Liu,Yang Ding,Chenxi Feng,Ziyi He,Qingyi Liu,Chenying Li,Hanzhang Yi,Jiachen Li,Kai Li,Zhixuan Xuan,Mengxi Gao,Yunlong Cao,Ge Gao,Jiang Chang,Dongxin Lin
标识
DOI:10.1158/2159-8290.cd-26-0691
摘要
Early detection of esophageal squamous cell carcinoma (ESCC) is hindered by a lack of noninvasive biomarkers for precancerous lesions. Here, we report a circulating cell-free DNA (cfDNA) methylation approach for early esophageal neoplasia detection. In prospective community screening, the assay achieved standardized sensitivity of 78% at 79% specificity for the clinically actionable endpoint of high-grade intraepithelial neoplasia (HGIN) or ESCC, with stage-specific sensitivities of 76% for HGIN and 86% for ESCC. Genome-wide methylation profiling reveals HGIN as an early epigenetic reprogramming stage. Integrative spatial and single-cell RNA sequencing reveals pronounced remodeling of the endothelial-proximal epithelial cell population, whose methylation signatures are detected in cfDNA. Guided by these findings, we develop an 11-gene cfDNA methylation panel that shows robust discrimination of early-stage ESCC across three retrospective case-control sets and an independent screening-derived case-control set. Together, these results demonstrate that our cfDNA methylation panel has promising utility for early ESCC detection.
科研通智能强力驱动
Strongly Powered by AbleSci AI